For us this is about increasing healthspan, not lifespan
Elysium Health hasn’t discovered the fountain of youth, but their new supplement—with the backing of some of the world’s foremost authorities on aging—could change how you get older
Say someone came up to you selling a dietary supplement—a pill that you take once a day—that could boost your energy, improve your body’s ability to repair its DNA, and keep you healthier as you get older.
It might sound like a scam, or more likely just another in a sea of confusing, undifferentiated claims that make up the $20 billion dollar supplement industry.
But let’s say that someone is MIT’s Lenny Guarente, one of the world’s leading scientists in the field of aging research. And he’s being advised by five Nobel Prize winners and two dozen other top researchers in their fields. You might pay a little more attention.
THE SCIENTIST AND THE STARTUP
Cofounding a supplement company seems an unlikely career move for someone like Guarente, a man who is one of the most well-respected scientists in his field. (“It is a departure,” Guarente admits). Mostly, for him, getting involved in Elysium Health is a decision born out of opportunity and frustration. The opportunity is the chance to make a difference by translating findings in the booming field of aging research directly to consumers today. The frustration is that doing this has taken so long in the first place.
“My biggest hope is that we can make available to people something that is currently unavailable, and that it will have a positive impact on their health,” Guarente says.
Elysium Health actually had its beginnings in conversations between its other two, younger cofounders, Eric Marcotulli and Dan Alminana, who were then tech investors and gym buddies. Even though they’re both quite health-conscious, they knew they couldn’t halt the march of aging and all the ailments that come with it. Far more than diet or anything else people can control, the biggest risk factor for many of the diseases that kill us—including diabetes, cancer, and cardiovascular disease—is simply getting older.
Marcotulli knew something about the market opportunity too, which has also lately attracted the likes of Google (with its Calico Labs project) and other SIlicon Valley investors. He had studied the story of a company called Sirtris Pharmaceuticals, which in the mid-2000s was working to take resveratrol, the natural anti-aging compound found in red wine, and alter it into a more potent form that could be patented and developed into a medical drug. In 2008, Sirtris—founded by Guarente’s former postdoc David Sinclair—was acquired by the drugmaker GlaxoSmithKline for a jaw-dropping $720 million.
“The fundamental question was: Are there other natural products out there that could be meaningful? I think resveratrol was the first, and I was thinking there’s maybe the potential for many others,” Marcotulli remembers thinking as he studied the story while in business school.
The two started cold-calling scientists involved in aging research and were surprised how many were enthusiastic about the idea, including Guarente. The FDA doesn’t recognize aging itself as a condition, so, instead, companies like Sirtris and GSK are are taking scientific findings about how we age and translating them into drugs that treat specific age-related diseases. The issue is that the clinical trials involved in doing this can take more than a decade, and even then that is no guarantee a drug will be approved. The result has been that, though scientists have made major strides in understanding how and why we age and demonstrating that this aging can be delayed, they’ve so far seen few results in translating their work to help people.
The Latest on: Healthspan
via Google News
The Latest on: Healthspan
- Life Biosciences Appoints Seasoned Biopharma Executive Jerry McLaughlin as CEOon July 1, 2021 at 10:14 am
Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced that the Company's Board of Directors ...
- Matt Kaeberlein to present at the 8th Aging Research & Drug Discovery Meeting 2021on June 30, 2021 at 9:00 pm
Matt Kaeberlein to present new research in the biology of aging at the world's largest aging research for drug discovery conference ...
- Osteoporosis drug could have the potential to increase healthspans for allon June 29, 2021 at 7:22 am
They tested the drug’s lifespan and healthspan extending properties on Drosophila, a type of fruit fly. Fruit flies were used because their genome is 60% homologous to that of humans and they are ...
- Trust the process? Why processed food isn't always bad for uson June 28, 2021 at 12:00 am
Although it's often associated with microwave meals, any food that has been altered during its preparation is considered to be processed – whether via freezing, frying, baking or canning. Most people ...
- A New Experiment Aims to Cure Aging Once and for Allon June 20, 2021 at 4:59 pm
The first area of focus for YC Bio is “healthspan” and age-related disease. Healthspan centers on the idea that medicine should not just help people live longer, but allow those people to ...
- InVivo Biosystems Launches New Formulation Analysis Platform to Aid Anti-Ageing Product Research and Developmenton June 15, 2021 at 7:43 am
"Using the best non-vertebrate model for longevity and healthspan studies, InVivo Longevity Platform specializes in giving clients a full picture of how each compound or test article impacts ...
- 20% off all Healthspan vitamins, supplements and sports nutritionon May 12, 2021 at 9:33 am
Healthspan is the UKs No.1 direct supplier of vitamins and supplements and one of our newest partners. Launched with just 5 products in 1996, the range now comprises of over 200 vitamins and ...
- Healthspan Discount Codeson August 17, 2020 at 10:17 am
At Healthspan, you'll find a range of nutritional supplements and special products. Vitamins, supplements, carefully selected herbal teas and more can all be purchased here. Look out for items ...
- Decoding the Relationship Between Ageing and Amyotrophic Lateral Sclerosison July 29, 2020 at 6:34 am
development of ALS models incorporating ageing and common aim of enhanced patient healthspan will ultimately provide life—quality and quantity—enhancing therapy for patients.
- Decoding the Relationship Between Ageing and Amyotrophic Lateral Sclerosison July 24, 2020 at 12:32 am
with the aim of enhancing healthspan and life expectancy. The human population is ageing, with an estimated 1.5 billion people expected to be 65+ years by 2050, triple the 2010 estimate (World ...
via Bing News